Results for “ ”

Entry Author Date Location
Boston Tech Watch: DraftKings Drives, The Engine Revs, NuTonomy Swaps 08/30/19 Boston
Celgene Adds Cell Therapies From Immatics With Bristol Sale in Sight 08/28/19 New York
ThoughtSpot Nabs $248M for Accessible Analytics, Nears $2B Valuation 08/28/19 San Francisco
Ionis Gets $25M From GSK for Experimental Hepatitis B Program 08/27/19 San Diego
NuTonomy Switches to Chrysler For More Elbow Room in Self-Driving Cars 08/27/19 Boston
New PCSK9 Cholesterol Drug Faces Tough Foe. (Hint: Not Cholesterol.) 08/26/19 National
VMware: “We Bought Carbon Black for $2.1B!” Analysts: “Oh… Why?” 08/23/19 Boston
GSK’s Cancer Comeback Continues With Data for Multiple Myeloma Drug 08/23/19 National
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More 08/23/19 National
Boston Tech Watch: Epstein, MIT Media Lab, Carbon Black, JRNI & More 08/23/19 Boston
VMware Dropping $4.8B to Buy Carbon Black, Pivotal Software 08/22/19 Boston
Healthcare’s Future is Telemedicine & AI, But Will Everyone Benefit? 08/22/19 Boston
Splunk To Pay $1B For SaaS App Monitoring Firm SignalFx 08/21/19 San Francisco
Ford’s Autonomic Connects EV Maker Ayro to Its Mobility Cloud 08/21/19 San Francisco
Xcelerate at Biotech Week Boston Discount Ticket Sale Ends Friday 08/21/19 National
Oncorus Adds $79.5M to Steer Cancer-Fighting Virus to Human Testing 08/21/19 Boston
FDA Rejects Sarepta’s Second Duchenne Drug, Citing Safety Concerns 08/19/19 Boston
Bio Roundup: Zolgensma Fallout, Duchenne Redux, Ebola Boost & More 08/16/19 National
Will Porsche Fans Ever Live in a Driverless World? Porsche Says No. 08/16/19 San Francisco
Boston Tech Watch: Buoy Health, Cambridge Crops, Polarity & More 08/16/19 Boston
Motif Unveils New Name and $27.5M to Build Food Ingredients Pipeline 08/15/19 Boston
Four New Drugs Are Around the Corner. Here’s What You Need to Know. 08/15/19 National
After Drought, Digital Health’s Summer of IPOs Brings Validation 08/14/19 National
Chasing Blueprint, Deciphera Plans FDA Filing for GI Cancer Drug 08/13/19 Boston
Vor Biopharma Appoints Neon’s Robert Ang President & CEO 08/12/19 Boston
Boston Tech Watch: Nike, Cybereason, Care.com, LaunchByte & More 08/09/19 Boston
Bayer Buys Out BlueRock, Betting at Least $240M More on Cell Therapy Work 08/08/19 Boston
Rhythm Pharma’s Obesity Drug Hits Phase 3 Goals, FDA Filing Planned 08/07/19 Boston
Women’s Health-Focused Luca Bio Takes Microbiome R&D Beyond the Gut 08/06/19 Boston
FDA: Despite “Manipulated” Data, $2M Gene Therapy Should Stay on Market 08/06/19 National
Page 2 of 372 « previous page · next page »